In English
NIDA

Naltrexone

Dr. Charles O’Brien Receives the James B. Isaacson Award for Lifetime Achievement

NIDA researcher Dr. Charles O’Brien recently received the James B. Isaacson Award for a lifetime of research on the biological basis of alcoholism.

Two NIDA Grantees Receive Sarnat Prize

Announces the recipients of the 2010 Rhoda and Bernard Sarnat International Prize in Mental Health, Dr. Eric J. Nestler and Dr. Charles P. O'Brien, prominent addiction scientists.

Lofexidine May Enhance Naltrexone Efficacy

Highlights results from a pilot study suggesting that lofexidine, an anti-hypertensive medication, can enhance success rates among patients taking maintenance naltrexone to avoid opioid relapse.

Combined Treatments Improve Dual Abstinence

Reports on a study investigating the effectiveness of a combined therapy of disulfiram and naltrexone for people who abuse cocaine and alcohol.

Naltrexone via Skin Patch Proves Effectiveness of New Technology

Reports on a new device that creates tiny painless punctures in the skin to allow medication to flow evenly from a skin patch into dermal capillaries and the bloodstream.

Detoxification Services and Pharmacotherapies Lacking in Nation's Jails and Prisons

Reports findings from a survey that revealed that although substance abuse is prevalent in jails and prisons, many correctional facilities do not offer detoxification services or therapies to aid in maintaining abstinence.
Subscribe to RSS - Naltrexone

Attention

Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at

Toma el reto nacional sobre el coeficiente intelectual (CI) sobre las drogas